Hyperfine, Inc. (HYPR)
0.8978
-0.03
(-3.53%)
USD |
NASDAQ |
Oct 12, 16:00
0.8978
0.00 (0.00%)
After-Hours: 20:00
Hyperfine Cash from Investing (Quarterly) : -0.03M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.03M |
| March 31, 2026 | -0.242M |
| December 31, 2025 | -0.063M |
| September 30, 2025 | -0.13M |
| June 30, 2025 | -0.52M |
| March 31, 2025 | -0.472M |
| December 31, 2024 | -0.008M |
| September 30, 2024 | -0.159M |
| June 30, 2024 | -0.071M |
| March 31, 2024 | -0.145M |
| December 31, 2023 | -0.258M |
| Date | Value |
|---|---|
| September 30, 2023 | -0.263M |
| June 30, 2023 | -0.222M |
| March 31, 2023 | -0.061M |
| December 31, 2022 | -0.158M |
| September 30, 2022 | -0.173M |
| June 30, 2022 | 0.054M |
| March 31, 2022 | -0.308M |
| December 31, 2021 | -0.975M |
| September 30, 2021 | -1.061M |
| June 30, 2021 | -0.505M |
| March 31, 2021 | -0.17M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -3.148M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
| Baxter International, Inc. | -117.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.268M |
| Cash from Financing (Quarterly) | 10.78M |
| Free Cash Flow | -27.53M |
| Free Cash Flow Per Share (Quarterly) | -0.0731 |
| Free Cash Flow to Equity (Quarterly) | -7.342M |
| Free Cash Flow to Firm (Quarterly) | -6.765M |
| Free Cash Flow Yield | -33.09% |